Dyno Therapeutics is Other Healthcare Technology Systems in United States that focus on machine learning business. Founded in 2018. They cover business area such as developer, novel adeno-associate virus, AI, next-generation DNA synthesis, million, AAV capsid, high-throughput sequencing, machine learning, medical researcher, (AAV, vector, vivo delivery, revolutionary new gene therapy.
Other Healthcare Technology Systems
2018
( 6 years old in 2024 )
Machine Learning
-
1 Kendall Square
Building 1400 East, Suite 202
Cambridge, MA 02139
United States
Private
developernovel adeno-associate virusAInext-generation DNA synthesismillionAAV capsidhigh-throughput sequencingmachine learningmedical researcher(AAVvectorvivo deliveryrevolutionary new gene therapy
* We use standard office opening hours in near Dyno Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Dyno Therapeutics is Other Healthcare Technology Systems business from United States that founded in 2018 (6 years old in 2024), Dyno Therapeutics business is focusing on Machine Learning.
Dyno Therapeutics headquarter office and corporate office address is located in 1 Kendall Square Building 1400 East, Suite 202 Cambridge, MA 02139 United States.
Dyno Therapeutics was founded in United States.
In 2024, Dyno Therapeutics is currently focus on machine learning sector.
Above is snippet of Google Trends for "machine learning" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Dyno Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
